NT5E and neoplasm: There was no statistical difference of age, sex, pathological N status, tumor location, and tumor grade between patients with high or low expression of CD73; however, patients with high expression of CD73 had higher percentage of advanced pathological T status and pathological tumor stage compared to those with low expression of CD73.